Background The coronavirus disease 2019 (COVID-19) caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to plague the world. While …

In a recent study of our group with the acronym ACTIVATE, Bacillus Calmete-Guérin (BCG)
vaccination reduced the occurrence of new infections compared to placebo vaccination in …

Abstract The Elecsys® Anti-SARS-CoV-2 S immunoassay (Roche Diagnostics International
Ltd, Rotkreuz, Switzerland) has been developed for the detection of antibodies to the severe …

Background The development of covid‐19 vaccinations represents a notable scientific
achievement. Nevertheless, concerns have been raised regarding their possible detrimental …

The SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) pandemic has posed a
huge threat to global health because of its rapid spread and various mutant variants. Critical …

There are currently eight vaccines against SARS-CoV-2 that have received Emergency Use
Authorization by the WHO that can offer some protection to the world's population during the …

With the accumulation of mutations in SARS-CoV-2 and the continuous emergence of new
variants, the importance of developing safer and effective vaccines has become more …

Vaccines constitute the most effective medications in public health as they control and
prevent the spread of infectious diseases and reduce mortality. Similar to other medications …

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection, has become a major threat to the global public health …

The “severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)” is the third member of
human coronavirus (CoV) that is held accountable for the current “coronavirus disease 2019 …